BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Kidney tumors AND FANCD2, FANCD, 2177, ENSG00000144554, FLJ23826, FAD, FACD, FA4, FA-D2, FAD2, DKFZp762A223
22 results:

  • 1. Neddylation inhibition sensitises renal medullary carcinoma tumours to platinum chemotherapy.
    Shapiro DD; Zacharias NM; Tripathi DN; Karki M; Bertocchio JP; Soeung M; He R; Westerman ME; Gao J; Rao P; Lam TNA; Jonasch E; Perelli L; Cheng EH; Carugo A; Heffernan TP; Walker CL; Genovese G; Tannir NM; Karam JA; Msaouel P
    Clin Transl Med; 2023 May; 13(5):e1267. PubMed ID: 37226898
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Inhibition of USP1 enhances anticancer drugs-induced cancer cell death through downregulation of survivin and miR-216a-5p-mediated upregulation of DR5.
    Woo SM; Kim S; Seo SU; Kim S; Park JW; Kim G; Choi YR; Hur K; Kwon TK
    Cell Death Dis; 2022 Sep; 13(9):821. PubMed ID: 36153316
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Screening of Differentially Expressed Iron Death-Related Genes and the Construction of Prognosis Model in Patients with Renal Clear Cell Carcinoma.
    Wu D; Xu Z; Shi Z; Li P; Lv H; Huang J; Fu D
    Comput Math Methods Med; 2022; 2022():4456987. PubMed ID: 36081434
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Renalase: a novel regulator of cardiometabolic and renal diseases.
    Vijayakumar A; Mahapatra NR
    Hypertens Res; 2022 Oct; 45(10):1582-1598. PubMed ID: 35941358
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. A novel ferroptosis-related 12-gene signature predicts clinical prognosis and reveals immune relevancy in clear cell renal cell carcinoma.
    Hong Y; Lin M; Ou D; Huang Z; Shen P
    BMC Cancer; 2021 Jul; 21(1):831. PubMed ID: 34281531
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Raloxifene, identified as a novel LSD1 inhibitor, suppresses the migration of renal cell carcinoma.
    Ma Y; Zheng Y; Ji Y; Wang X; Ye B
    Future Med Chem; 2021 Mar; 13(6):533-542. PubMed ID: 33527838
    [No Abstract]    [Full Text] [Related]  

  • 7. Identification of fenoldopam as a novel LSD1 inhibitor to abrogate the proliferation of renal cell carcinoma using drug repurposing strategy.
    Zheng Y; Ma Y; Cao H; Yan L; Gu Y; Ren X; Jiao X; Wan S; Shao F
    Bioorg Chem; 2021 Mar; 108():104561. PubMed ID: 33349457
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. In vitro evidence of NLRP3 inflammasome regulation by histone demethylase LSD2 in renal cancer: a pilot study.
    Kumar A; Nallabelli N; Sharma U; Kumari N; Singh SK; Kakkar N; Prasad R
    Mol Biol Rep; 2020 Sep; 47(9):7273-7276. PubMed ID: 32754863
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. A new survival model based on ferroptosis-related genes for prognostic prediction in clear cell renal cell carcinoma.
    Wu G; Wang Q; Xu Y; Li Q; Cheng L
    Aging (Albany NY); 2020 Jul; 12(14):14933-14948. PubMed ID: 32688345
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Role of the ERO1-PDI interaction in oxidative protein folding and disease.
    Shergalis AG; Hu S; Bankhead A; Neamati N
    Pharmacol Ther; 2020 Jun; 210():107525. PubMed ID: 32201313
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Identification of Hub Genes in High-Grade Serous Ovarian Cancer Using Weighted Gene Co-Expression Network Analysis.
    Wu M; Sun Y; Wu J; Liu G
    Med Sci Monit; 2020 Mar; 26():e922107. PubMed ID: 32180586
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. [Stereotactic body radiotherapy: Passing fad or revolution?].
    Vallard A; Vial N; Jmour O; Rehailia-Blanchard A; Trone JC; Sotton S; Daguenet E; Guy JB; Magné N
    Bull Cancer; 2020 Feb; 107(2):244-253. PubMed ID: 31864665
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Analysis of polymorphisms in genes associated with the FA/BRCA pathway in three patients with multiple primary malignant neoplasms.
    Wang L; Wang H; Wang T; Liu J; Chen W; Wang Y; Chen C; Zhu H; Dai P
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):1101-1112. PubMed ID: 30942098
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. A study for the detection of kidney cancer using fluorescence emission spectra and synchronous fluorescence excitation spectra of blood and urine.
    Atif M; AlSalhi MS; Devanesan S; Masilamani V; Farhat K; Rabah D
    Photodiagnosis Photodyn Ther; 2018 Sep; 23():40-44. PubMed ID: 29800712
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Next-generation sequencing reveals germline mutations in an infant with synchronous occurrence of nephro- and neuroblastoma.
    Theruvath J; Russo A; Kron B; Paret C; Wingerter A; El Malki K; Neu MA; Alt F; Staatz G; Stein R; Seidmann L; Prawitt D; Faber J
    Pediatr Hematol Oncol; 2016 May; 33(4):264-75. PubMed ID: 27285993
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Detection of an Immunogenic HERV-E Envelope with Selective Expression in Clear Cell kidney Cancer.
    Cherkasova E; Scrivani C; Doh S; Weisman Q; Takahashi Y; Harashima N; Yokoyama H; Srinivasan R; Linehan WM; Lerman MI; Childs RW
    Cancer Res; 2016 Apr; 76(8):2177-85. PubMed ID: 26862115
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Clinical and molecular characterization of Brazilian families with von Hippel-Lindau disease: a need for delineating genotype-phenotype correlation.
    Gomy I; Molfetta GA; de Andrade Barreto E; Ferreira CA; Zanette DL; Casali-da-Rocha JC; Silva WA
    Fam Cancer; 2010 Dec; 9(4):635-42. PubMed ID: 20567917
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. What is the role of percutaneous needle core biopsy in diagnosis of renal masses?
    Sofikerim M; Tatlisen A; Canoz O; Tokat F; Demirtas A; Mavili E
    Urology; 2010 Sep; 76(3):614-8. PubMed ID: 20110106
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Molecular pathology of the MEN1 gene.
    Agarwal SK; Lee Burns A; Sukhodolets KE; Kennedy PA; Obungu VH; Hickman AB; Mullendore ME; Whitten I; Skarulis MC; Simonds WF; Mateo C; Crabtree JS; Scacheri PC; Ji Y; Novotny EA; Garrett-Beal L; Ward JM; Libutti SK; Richard Alexander H; Cerrato A; Parisi MJ; Santa Anna-A S; Oliver B; Chandrasekharappa SC; Collins FS; Spiegel AM; Marx SJ
    Ann N Y Acad Sci; 2004 Apr; 1014():189-98. PubMed ID: 15153434
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Human CRYL1, a novel enzyme-crystallin overexpressed in liver and kidney and downregulated in 58% of liver cancer tissues from 60 Chinese patients, and four new homologs from other mammalians.
    Chen J; Yu L; Li D; Gao Q; Wang J; Huang X; Bi G; Wu H; Zhao S
    Gene; 2003 Jan; 302(1-2):103-13. PubMed ID: 12527201
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.